Table 3 Estimated and measured levels of n-3 PUFAs. All data are shown as median (IQR).
n-3 PUFA Levels of Total Cohort (n = 307) | |
|---|---|
ALA | |
Estimated intake, mg/week | 2487.0 (1141.0–5889.0) |
Measured serum levels, % of total fatty acids | 0.74 (0.61–0.89) |
EPA | |
Estimated intake, mg/week | 351.6 (127.5–832.2) |
Measured serum levels, % of total fatty acids | 0.60 (0.47–0.75) |
DHA | |
Estimated intake, mg/week | 820.0 (224.4–1457.7) |
Measured serum levels, % of total fatty acids | 2.57 (2.16–2.98) |
DPA | |
Estimated intake, mg/week | 306.6 (170.2-459.3) |
Measured serum levels, % of total fatty acids | 0.50 (0.43–0.62) |
Total long-chain n-3 PUFAs * | |
Estimated intake, mg/week | 1431.0 (630.1–2682.9) |
Measured serum levels, % of total fatty acids | 3.73 (3.14–4.19) |
Total n-3 PUFAs †| |
Estimated intake, mg/week | 4648.0 (2285.0–8728.0) |
Measured serum levels, % of total fatty acids | 4.47 (3.96–4.96) |